SGMO

NASDAQStock

Sangamo Therapeutics, Inc.

$0.38-0.01 (-3.43%)

52-Week Range

$0.35
$1.01

Key Stats

Market Cap

142.2M

P/E Ratio

Dividend Yield

Beta

1.32

Volume

3.4M

Avg Volume

3.9M

Performance

1M

+4.57%

3M

-9.98%

6M

-20.83%

YTD

-9.69%

1Y

-59.63%

3Y

-81.66%

5Y

-96.65%

Price Chart

ETF Exposure

SGMO is held by 21 ETFs

ETFFund NameWeight
MSGRDirexion mRNA ETF2.26%
QQQSInvesco NASDAQ Future Gen 200 ETF0.43%
GNOG.LGlobal X - Genomics & Biotechnology UCITS ETF0.20%
GNOM.LGlobal X - Genomics & Biotechnology UCITS ETF0.20%
GNOMGlobal X - Genomics & Biotechnology ETF0.19%
IBRNiShares Neuroscience and Healthcare ETF0.18%
PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.18%
STSBiShares Factors US Small Blend Style ETF0.04%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.01%
SCHASchwab U.S. Small-Cap ETF0.00%
VXFVanguard Extended Market ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%

About SGMO ETF Exposure

Sangamo Therapeutics, Inc. (SGMO) is held by 21 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 142.2M, SGMO is a widely held institutional stock. The stock currently trades at $0.38. Investors can gain exposure to SGMO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SGMO, sorted by portfolio weight.